EANS-Adhoc: LIFEWATCH TEAMS WITH UNITEDHEALTHCARE, THE LARGEST HEALTHCARE INSURER IN THE UNITED STATES, AS A PREFERRED NATIONAL PROVIDER OF CARDIAC MONITORING SERVICES TO REDUCE PATIENT COSTS (with document)
Ein Dokument
-------------------------------------------------------------------------------- ad-hoc disclosure transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------------
Company Information/LifeWatch AG
21.02.2011
Neuhausen am Rheinfall/Switzerland und Rosemont/Illinois - LifeWatch AG (SIX Swiss Exchange: LIFE), the leading provider of wireless telemedicine, today announces an initiative with UnitedHealthcare Insurance Company, an affiliate of United-Health Group (NYSE: UNH) that will provide members insured by UnitedHealthcare in-network access to LifeWatch cardiac monitoring services and technologies. LifeWatch is proud to continue our preferred national relationship that began December 1, 2006. The purpose of this initiative is to substantially reduce patient co-pays and deductibles associated with the use of out-of-network cardiac monitoring services provided by other monitoring services.
You will find a PDF version of this press release at the end of this message.
LifeWatch is the leading independent provider of remote cardiac arrhythmia monitoring devices, home sleep studies and services in the USA, which assist physicians and patients in the early detection and treatment of arrhythmia and Obstructive Sleep Apnea (OSA), and can thus prevent heart diseases, stroke, or sudden cardiac death. Millions of people experience arrhythmia and sleep apnea. Typical arrhythmia symptoms include palpitations, rapid heartbeat, dizziness, chest pain and shortness of breath. OSA patients are at risk for a multitude of comorbidities including atrial fibrillation. LifeWatch´s services enable a physician who is treating a patient with arrhythmia to prescribe his patient with a range of cardiac monitoring devices that records irregularities in the heart´s electrical activity up to a 30-day period. The recorded data is transmitted to the LifeWatch call center, which processes the information and sends a detailed report to the referring physician for interpretation and treatment decisions. Making the LifeWatch services in-network simplifies the process by which a doctor can prescribe them to patients who are insured by UnitedHealthcare.
"LifeWatch is privileged to continue our existing relationship with UnitedHealthcare," said Yacov Geva, LifeWatch president and CEO. "Our agreement strengthens the position of our Client Executives when they approach physicians, health care professionals, and hospitals that are members of the UnitedHealthcare network. Our agreement also provides UnitedHealthcare and their members with an all-inclusive in-network provider for remote cardiac monitoring services. UnitedHealthcare contracted providers are assured access to state of the art devices and reporting for their patients´ cardiac monitoring care."
LifeWatch is accredited from the Joint Commission on Accreditation of Healthcare Organizations (The Joint Commission) under the program classification of "Ambulatory Health Care Programs." LifeWatch is one of only a few independent diagnostic testing facilities worldwide that have received this Gold Seal of ApprovalTM.
Sign-up for customized E-mail alerts and documentation requests is available at http://production.investis.com/lifewatch/alert-service/
About LifeWatch AG:
LifeWatch AG, headquartered in Neuhausen am Rheinfall, Switzerland and listed on SIX Swiss Exchange (LIFE), is the leading healthcare technology and solutions company, specializing in advanced telemedicine systems and wireless remote patient monitoring services. LifeWatch provides services to high-risk and chronically ill patients, health conscious consumers and wellness programs. LifeWatch has subsidiaries in the United States, the Netherlands, Japan, the United Kingdom, Switzerland and Israel. LifeWatch AG is the parent company of LifeWatch Services, Inc., a leading US-based wireless remote telemedicine provider. LifeWatch services include Home Sleep Testing for Obstructive Sleep Apnea patients under the brand name NiteWatch. For additional information, please visit www.lifewatch.com and www.nitewatchservices.com.
About UnitedHealthcare:
UnitedHealth Group is a diversified health and well-being company dedicated to helping people live healthier lives and making health care work better. With headquarters in Minnetonka, Minn., UnitedHealth Group offers a broad spectrum of products and services through six operating businesses: UnitedHealthcare Employer & Individual, UnitedHealthcare Medicare & Retirement, UnitedHealthcare Community & State, OptumHealth, Ingenix and Prescription Solutions. Through its family of businesses, UnitedHealth Group serves more than 75 million people worldwide. Visit www.unitedhealthgroup.com for more information.
This press release includes forward-looking statements. All statements other than statements of historical facts contained in this press release, including statements regarding future results of operations and financial position, business strategy and plans and objectives for future operations, are forward- looking statements. The words "believe," "may," "will," "estimate," "continue," "anticipate," "intend," "expect" and similar expressions are intended to identify forward-looking statements. LifeWatch AG has based these forward- looking statements largely on current expectations and projections about future events and financial trends that it believes may affect the financial condition, results of operations, business strategy, short term and long term business operations and objectives, and financial needs. These forward-looking statements are subject to a number of risks, uncertainties and assumptions. In light of these risks, uncertainties and assumptions, the forward-looking events and circumstances described may not occur and actual results could differ materially and adversely from those anticipated or implied in the forward- looking statements. All forward-looking statements are based only on data available to LifeWatch AG at the time of the issue of this press release. LifeWatch AG does not undertake any obligation to update any forward-looking statements contained in this press release as a result of new information, future events or otherwise.
THIS PRESS RELEASE IS NOT BEING ISSUED IN THE UNITED STATES OF AMERICA AND SHOULD NOT BE DISTRIBUTED TO UNITED STATES PERSONS OR PUBLICATIONS WITH A GENERAL CIRCULATION IN THE UNITED STATES. THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER OF SECURITIES OF LIFEWATCH AG OR ANY OF ITS SUBSIDIARIES FOR SALE IN THE UNITED STATES OR AN INVITATION TO SUBSCRIBE FOR OR PURCHASE ANY SECURITIES OF LIFEWATCH AG OR ITS SUBSIDIARIES IN THE UNITED STATES. IN ADDITION, THE SECURITIES OF LIFEWATCH AG AND ITS SUBSIDIARIES HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES LAWS AND MAY NOT BE OFFERED, SOLD OR DELIVERED WITHIN THE UNITED STATES OR TO U.S. PERSONS ABSENT REGISTRATION UNDER OR AN APPLICABLE EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE UNITED STATES SECURITIES LAWS. ANY PUBLIC OFFERING OF SECURITIES TO BE MADE IN THE UNITED STATES WILL BE MADE BY MEANS OF A PROSPECTUS THAT MAY BE OBTAINED FROM LIFEWATCH AG OR ITS SUBSIDIARIES, AS APPLICABLE, AND WILL CONTAIN DETAILED INFORMATION ABOUT THE ISSUER AND ITS MANAGEMENT AS WELL AS FINANCIAL STATEMENTS OF THE ISSUER.
Attachments with Announcement: ---------------------------------------------- http://resources.euroadhoc.com/us/l6A8sZUQ
end of announcement euro adhoc --------------------------------------------------------------------------------
Contact:
Woo Kim, Senior Vice President of Strategy and Business Development, LifeWatch
Tel +1 847 813 4299 | Fax +1 847 813 2448 | E-mail: wkim@lifewatch.com
Sensus Investor & Public Relations, Zürich:
Tel +41 43 366 55 11 | Fax +41 43 366 55 12 | E-mail: lifewatch@sensus.ch
Branche: Healthcare Providers
ISIN: CH0012815459
WKN: 1281545
Index: SPI, SPIEX
Börsen: Frankfurt / Open Market / XETRA
Berlin / free trade
SIX Swiss Exchange / Main Standard